Drug-resistant tuberculosis (TB) can sometimes evade detection through standard diagnostic tests, creating challenges for timely and accurate treatment. When resistance goes undetected, patients may continue receiving ineffective medicines, allowing the disease to progress and potentially spread.
Hidden Drug Resistance
Standard TB tests may not always detect certain resistance patterns, particularly when drug-resistant bacteria are present in small numbers. As a result, patients can receive a diagnosis that does not fully reflect the drug susceptibility of the infection.
As per The Hindu BusinessLine, researchers have highlighted how drug-resistant TB can escape detection in conventional testing, underlining the need for more sensitive diagnostic approaches.
Need for Advanced Diagnostics
Therefore, improving diagnostic tools remains critical to identifying drug resistance at an early stage. More comprehensive testing can help doctors select effective treatment regimens sooner, reduce treatment failure and limit the transmission of resistant TB.
Strengthening TB diagnostics alongside wider access to advanced testing could play an important role in tackling drug-resistant TB and improving treatment outcomes.



















